Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Mobile home BP monitoring with coaching after high blood pressure from pregnancy

Official title: Multilevel Mobile Health Program to Improve Hypertension Among Midlife Women After Hypertensive Disorder of Pregnancy

Run by University of Pittsburgh · NCT07599579 · Data updated 2026-11-12

This program tests whether a home blood pressure monitoring system plus virtual coaching can help midlife women, 10–20 years after a hypertensive pregnancy, manage high blood pressure better than usual care.

More Preeclampsia trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment50 (estimated)
SponsorUniversity of Pittsburgh
Academic / other
Locations1 site (Pittsburgh, Pennsylvania)
StatusRecruiting
StartedJuly 22, 2026
Main results expectedJuly 2027
Study endsOctober 2027
Registry record updatedJuly 29, 2026
Trial IDNCT07599579 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 10–20 years postpartum with a history of HDP (gestational hypertension or preeclampsia) and current stage 2 hypertension (BP ≥ 140/90 mmHg).

Probably not a fit

Individuals without persistent hypertension or with established cardiovascular disease may not derive benefit from this specific intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention study tests a home blood pressure monitoring program combined with virtual coaching versus standard care for women 10 to 20 years after hypertensive disorders of pregnancy who now have stage 2 hypertension. Participants will use a coaching app and home BP monitoring to guide treatment and lifestyle changes, with an unblinded assignment to either the intervention or control group. The goal is to determine whether this approach improves blood pressure control and engagement in care. The study is led by the University of Pittsburgh at UPMC Magee-Womens Hospital, with support from the McKamish Family Foundation. Recruitment is limited to women with a history of gestational hypertension or preeclampsia and current uncontrolled hypertension, excluding those with existing clinical cardiovascular disease or who do not fit the postpartum window.

Why it matters

Potential benefit: If successful, the approach could improve blood pressure control and reduce cardiovascular risk for women years after a hypertensive pregnancy.

How similar studies have gone: Previous work supports home BP monitoring and coaching for hypertension, but applying it specifically to long-term post-HDP women is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women who had a history of HDP (either gestational HTN or preeclampsia) diagnosed by ACOG guidelines at the time of delivery at Magee-Womens Hospital between 2008 and 2015, thus 10 to 20 years from their index pregnancy complicated by HDP.
* Evidence of current stage 2 HTN (BP ≥ 140/90 mmHg with or without treatment with antihypertensive medication).

Exclusion Criteria:

* Known clinical CVD (prior myocardial infarction, stroke, heart failure, or peripheral arterial disease).
* Males will also be excluded from this study as it focuses on pregnancy related conditions.
* Children will be excluded as the study is only recruiting people who are 10-20 years postpartum.

Where it's running

  • UPMC Magee Womens Hospital
    Pittsburgh, Pennsylvania, United States
    Recruiting

Study contacts

  • Principal investigator: Malamo Countouris, MD, MS — University of Pittsburgh
  • Study coordinator: Amy Travis
  • Email: travisam@upmc.edu
  • Phone: 4126413295

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.